Trials / Completed
CompletedNCT00433199
Testosterone Treatment for Hypogonadal Men
A Multi-Center, Randomized, Double-Blind,Placebo-Controlled Efficacy and Safety Study of Testosterone Gel 1.62% for the Treatment of Hypogonadal Men
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 274 (actual)
- Sponsor
- Abbott · Industry
- Sex
- Male
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Demonstrate efficacy and safety of Testosterone Gel 1.62% for the treatment of hypogonadal men
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testosterone (T) Gel 1.62% | Testosterone gel 1.62% contains 1.62% testosterone gel as active ingredient. |
| DRUG | Placebo | Placebo Control |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2007-10-01
- Completion
- 2008-04-01
- First posted
- 2007-02-09
- Last updated
- 2015-01-27
- Results posted
- 2011-12-08
Source: ClinicalTrials.gov record NCT00433199. Inclusion in this directory is not an endorsement.